Home » Topics » Regulatory

Regulatory
RSS

FDA approves first antifungal agent for prevention of IFIs caused by Aspergillus

Sep. 19, 2006

German approval for Foster in asthma

Aug. 31, 2006

Keppra receives FDA approval for juvenile myoclonic epilepsy

Aug. 24, 2006

CE Mark for Repel-CV to reduce adhesions following cardiac surgery

Aug. 24, 2006

Mexico first to approve Januvia

Aug. 9, 2006

ATryn approved for use in E.U.

Aug. 3, 2006

Xolegel approved for seborrheic dermatitis

July 31, 2006

Famvir approved for recurrent genital herpes and cold sores

July 31, 2006

duetact approved for type 2 diabetes

July 31, 2006

Zanitek receives German approval

July 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...